Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

ClinicalTrials.gov ID: NCT01836042

Public ClinicalTrials.gov record NCT01836042. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 30, 2026, 10:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent System In Conjunction With Cataract Surgery: Extended Follow-up of the Premarket Cohort

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100R/L in subjects previously enrolled in Glaukos Study GC-003.

Study identification

NCT ID: NCT01836042
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Glaukos Corporation; Industry
Enrollment: 108 participants

Conditions and interventions

Conditions

Primary Open Angle Glaucoma

Interventions

Not listed

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 2013 (Type not available)
Primary completion: Apr 2014 (Actual)
Completion: Apr 2014 (Actual)
Last update posted: Apr 15, 2016

2013 – 2014

United States locations

U.S. sites: 26
U.S. states: 16
U.S. cities: 26

Facility	City	State	ZIP	Site status
Not listed	Beverly Hills	California	90210	—
Not listed	Petaluma	California	94954	—
Not listed	Sacramento	California	95817	—
Not listed	San Clemente	California	92673	—
Not listed	Santa Maria	California	93454	—
Not listed	Parker	Colorado	80134	—
Not listed	Boynton Beach	Florida	33426	—
Not listed	Miami	Florida	33176	—
Not listed	Tampa	Florida	33603	—
Not listed	Morrow	Georgia	30260	—
Not listed	Indianapolis	Indiana	46260	—
Not listed	Overland Park	Kansas	66213	—
Not listed	Louisville	Kentucky	40206	—
Not listed	Baton Rouge	Louisiana	70806	—
Not listed	Saint Joseph	Michigan	49085	—
Not listed	Bloomington	Minnesota	55431	—
Not listed	Edina	Minnesota	55435	—
Not listed	Independence	Missouri	64055	—
Not listed	Kansas City	Missouri	64133	—
Not listed	Las Vegas	Nevada	89121	—
Not listed	Winston-Salem	North Carolina	27101	—
Not listed	Cincinnati	Ohio	45242	—
Not listed	Brookville	Pennsylvania	15825	—
Not listed	Philadelphia	Pennsylvania	19107	—
Not listed	Pittsburgh	Pennsylvania	15122	—
Not listed	Beaumont	Texas	77702	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01836042, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 15, 2016 · Synced Oct 30, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01836042 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →